| Term 
 | Definition 
 
        | Class: alpha blocker 
 Mechanism: nonselective competitive alpha antagonist
 
 Indication: phemochromocytoma
 
 Adverse effects: excess cardiac stimulation (dec. autofeedback alpha2)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class: alpha blocker 
 Mechanism: nonselective irreversible alpha antagonist
 
 Indication: pheochromocytoma
 
 Adverse effect: excess cardiac stimulation (dec. autofeedback alpha2)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class: alpha blocker 
 Mechanism: alpha1 selective competitive antagonist, decreases TVR via dec. sympathetic input to SMCs
 
 Indication: HTN, CHF, BPH
 
 Adverse effect: first dose phenomenon (hypotension/syncope)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class: alpha blocker 
 Mechanism: alpha1 selective competitive antagonist, dec. TVR via dec. sympathetic to SMCs
 
 Indication: HTN, CHF, BPH
 
 Adverse effects: first dose phenomenon (hypotension/syncope)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class: alpha blocker 
 Mechanism: alpha1 selective competitive antagonist, bladder selective (relaxes SMC of bladder neck, prostate capsule, and prostatic urethra)
 
 Indication: BPH
 
 Adverse effects: ejaculatory dysfunction, less hypotension that prazosin
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class: beta agonist 
 Mechanism: beta1 and beta2 agonist
 
 Indication: few (generally other adrenergics are better)
 
 Adverse effects: cardiac arrhythmias (inc. mortality)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class: beta agonist 
 Mechanism SHORT-ACTING beta2 selective agonist
 
 Indication: asthma (rescue therapy), COPD; 1ST LINE FOR ACUTE ASTHMATIC BRONCHOSPASM
 
 Adverse effects: potential for CV effects; tremors, duration only 3-4hrs
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class: beta agonist 
 Mechanism: SHORT-ACTING beta2 selective, (relax bronchial and uterine SMC)
 
 Indication: rescue therapy asthma, (unlabeled: prevent preterm labor)
 
 Adverse effects: CV effects potentially, tremors;
 NO LONGER THAN 48-72HRS IN PREGNANCY, MONITOR BOTH HEART BEATS
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class: beta agonist 
 Mechanism: LONG-ACTING beta2 agonist
 
 Indicataion: asthma prophylaxis (NEVER ALONE, use with corticosteroids)
 
 Adverse effects: inc. asthma-related deaths when monotherapy,
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class: beta agonist 
 Mechanism: B3 selective agonist, relaxes detrusor SMC during urine storage (inc. capacity)
 
 Indication: overactive bladder
 
 Adverse effects: HTN, slow onset (up to 8wks)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class: antimuscarinic 
 Mechanism: nonselective muscarinic antagonist, therapeutically action selective for bladder (dec. detrusor muscle tone, increase bladder capacity)
 
 Indication: overactive bladder
 
 Adverse effects: typical anticholinergic effects (much lower than other antimuscarinics)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class: antimuscarinic 
 Mechanism: M3 selective antagonist
 
 Indication: overactive bladder
 
 Adverse effects: (less constipation, less confusion), dry mouth and constipation most common
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class: antimuscarinic 
 Mechanism: nonselective muscarinic antagonist similar to atropine
 
 Indication: COPD and sometimes for asthma
 
 Advere effects: few b/c poor absorption; toxic dose - hypotension (ganglia blocked), muscle weakness (NMJ block)
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class: antitussive 
 Mechanism: NMDA receptor antagnoist, ?? other binding sites; D-isomer of mehtorphan (analog of codeine)
 
 Indication: cough
 
 Adverse effects: nothing really, @ high dose-tachycardia, agitation, pyschosis, seizure, ataxia, coma; abuse potential
 PROHIBITED IN CHILDREN <6y/o
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class: antitussive 
 Mechanism: irritate gastric mucosa and gastric nerve to stimulate cough reflex, stimulate resp. tract secretions to increase resp. fluid volumes and decrease mucous viscosity
 
 Indication: expectorant
 
 Adverse effects: few
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class: beta agonist 
 Mechanism: stimulates all alpha and beta receptors
 
 Indication: treat bronchospasms, bronchial asthma, viral croup, anaphylactic rxns
 
 Adverse effects: nonselective alpha and beta activation (tachycardia, arrhythmias, anxiety, tremors); low bioavailability
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class: antitussive 
 Mechanism: agonist at mu opioid receptor, ?? mechanism for antitussive
 
 Indication: mild-moderate pain (esp. combined with aspirin/acetaminophen), ANTITUSSIVE, antidiarrheal
 
 Adverse effects: constipation, respiratory depression (RARE)
 |  | 
        |  |